FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

36384311000001109: Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111342001000001116 Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111342101000001115 Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Is a Ondansetron 8mg tablets 10 tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has AMP Ondansetron 8mg tablets (Cipla EU Ltd) true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has presentation strength numerator value 8 false Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has precise active ingredient Ondansetron true Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has specific active ingredient Ondansetron hydrochloride true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start